Recent Press Releases

October 2017

Castle Creek Pharmaceuticals Receives Partners in Progress Award from debra of America

Company recognized for clinical research in epidermolysis bullosa simplex at the 19th Annual debra of America Benefit PARSIPPANY, NJ – [...]

September 2017

Castle Creek Pharmaceuticals Announces First IGA Scale for Epidermolysis Bullosa Simplex Clinical Research

Company also presents findings from proof-of-concept study of diacerein 1% ointment at 47th Annual ESDR Meeting 2017. PARSIPPANY, NJ – [...]

June 2017

Castle Creek Pharmaceuticals Announces First Patient Enrolled in DELIVERS Study of Diacerein 1% Ointment for Epidermolysis Bullosa Simplex

International randomized, double-blind, parallel group Phase 2/3 clinical trial to evaluate safety and efficacy of potentially disease-modifying therapy PARSIPPANY, NJ [...]

March 2017

December 2016

November 2016

October 2016

September 2016

© 2016 Castle Creek Pharma  -  Terms & Conditions  -  Privacy Policy

Powered by